Monsanto Roundup Lawsuit

Thursday, June 07, 2007

GlaxoSmithKline's 'Belly' laugh

Source: CNN Health

Part of this article made me spit coffee over my monitor when I read it and break into an uncontrolable fit of laughter. See if you can guesss which line projected Nescafe onto the monitor! (hint red text)

NEW YORK (AP) -- You will not lose weight in your sleep or shed pounds while eating anything you want -- that's the sobering message from the maker of a weight loss pill poised to hit shelves next month.

GlaxoSmithKline on Tuesday opened an educational exhibit in New York City to prepare the country for alli, the first over-the-counter diet pill approved by the Food and Drug Administration.

While the cautionary marketing approach may not trigger stampedes to the counter, analysts say the drug's fate hinges on the pharmaceutical giant's ability to convince people that diet pills aren't a magic bullet.

"People's hopes are ridiculously high when it comes to diet pills. That leads to disappointment and bad word of mouth," said Steven Brozak, an analyst with WBB Securities.

That's just what happened to the prescription version of the drug, Xenical by Roche Holding, which contains twice the dosage. People were let down when it failed to deliver dramatic results and the drug never really caught on, Brozak said.

GlaxoSmithKline has apparently learned the lesson and is counting on alli to become a star money maker. The company is spending $150 million on marketing alli this year, making it one of the drug maker's biggest campaigns to date.

"We've done everything to go out of our way to be honest," said Steve Burton, vice president of the weight control division at GlaxoSmithKline Consumer Healthcare. "We're taking a very different approach than the fad diets people are constantly exposed to."

Apologies if you are currently doubled up laughing